Drugmaker GlaxoSmithKline has agreed to settle almost 200 cases in which plaintiffs allege the use of the antidepressant Paxil caused birth defects.
Only one case in Philadelphia’s mass tort Paxil program has gone to trial.
GlaxoSmithKline has agreed to settle for confidential amounts almost 200 cases in which plaintiffs allege that the use of the antidepressant Paxil caused birth defects. One particular case that GSK has agreed to settle -- Kilker v. SmithKline Beecham Corp. d/b/a GlaxoSmithKline -- was viewed by the plaintiffs mass torts bar as a leading indicator of the strength of more than 600 similar cases.
June 23, 2010 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Drugmaker GlaxoSmithKline has agreed to settle almost 200 cases in which plaintiffs allege the use of the antidepressant Paxil caused birth defects.
Only one case in Philadelphia’s mass tort Paxil program has gone to trial.
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS